Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • World View
  • Published:

Our AI future is better than you think

Use of AI-driven care for patients with type 1 diabetes has freed up clinicians’ time to focus on patients’ quality of life and provide more empathic, patient-centered care.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations


Corresponding author

Correspondence to Aaron B. Neinstein.

Ethics declarations

Competing interests

A.N. has served as advisor and received consulting fees from Roche, Sanofi, Medtronic, Eli Lilly, Steady Health, and Intuity Medical, has served as unpaid advisor for Tidepool, has received research grants from Eli Lilly, Pfizer, Royal Philips, Commonwealth Fund and Cisco, and has received author and speaker honoraria from TCOYD, The Doctors Company, Medscape/WebMD and AcademyHealth.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Neinstein, A.B. Our AI future is better than you think. Nat Med 28, 2254 (2022).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing